BIOMAT Database Logo BIOMAT Database Logo

[Transient gynecomastia during treatment with D-penicillamine]. 1984

D Salliere, and D Clerc, and M Bisson, and P Massias

UI MeSH Term Description Entries
D008297 Male Males
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

D Salliere, and D Clerc, and M Bisson, and P Massias
Observations during treatment of cystinuria with D-penicillamine.
May 1971, Acta medica Scandinavica,
D Salliere, and D Clerc, and M Bisson, and P Massias
[Immune deficiency during D-penicillamine treatment ].
November 1977, La Nouvelle presse medicale,
D Salliere, and D Clerc, and M Bisson, and P Massias
IgA deficiency during D-penicillamine treatment.
February 1977, British medical journal,
D Salliere, and D Clerc, and M Bisson, and P Massias
[Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
January 1984, Therapie,
D Salliere, and D Clerc, and M Bisson, and P Massias
Neonatal abnormalities associated with D-penicillamine treatment during pregnancy.
January 1977, The New England journal of medicine,
D Salliere, and D Clerc, and M Bisson, and P Massias
[Myasthenic syndrome during treatment with D penicillamine. A recent case].
January 1977, Annales de medecine interne,
D Salliere, and D Clerc, and M Bisson, and P Massias
[Erythema nodosum and cholestatic hepatitis during treatment with D-penicillamine].
September 1983, Presse medicale (Paris, France : 1983),
D Salliere, and D Clerc, and M Bisson, and P Massias
[Dermatological complications during treatment of Wilsons disease with D-penicillamine].
January 1973, Medecine & chirurgie digestives,
D Salliere, and D Clerc, and M Bisson, and P Massias
[Nephrotic syndrome with minimal glomerular lesions during treatment with D-penicillamine].
October 1980, La Nouvelle presse medicale,
D Salliere, and D Clerc, and M Bisson, and P Massias
Hypocupremia-related hypochromic anemia during D-penicillamine treatment.
January 1982, Arthritis and rheumatism,
Copied contents to your clipboard!